Grosse Studie: Vapen ist ziemlich sicher krebserregend Lange war die Forschung zurückhaltend, jetzt sehen australische Wissenschaftler besorgniserregende Veränderungen in den Lungen und Mundhöhlen von Vapern.

Forscher ziehen ein eindeutiges Fazit: #Nikotin -haltige #EZigaretten verursachen wahrscheinlich Mund- und #Lungenkrebs.
Ob #Vapes seltener #Krebs verursachen als #Zigaretten, wird sich erst zeigen, denn Tumore bilden sich oft erst nach Jahrzehnten.
#vapen #rauchen #Lunge #Nitrosamine #Jugendschutz

Piramal Pharma Solutions: Meeting Global Regulatory Standards for Nitrosamine Contaminants Piramal Pharma Solutions has implemented extensive measures to comply with evolving regulations surrounding nitrosamine impurities in pharmaceuticals.

Piramal Pharma Solutions: Meeting Global Regulatory Standards for Nitrosamine Contaminants #India #Mumbai #pharmaceuticals #Piramal_Pharma #Nitrosamine

Piramal Pharma Solutions Meets Global Compliance for Nitrosamine Contaminants Piramal Pharma Solutions has successfully aligned with global regulations targeting nitrosamine impurities in pharmaceuticals. This achievement ensures the safety and compliance of their drug products.

Piramal Pharma Solutions Meets Global Compliance for Nitrosamine Contaminants #India #Mumbai #CDMO #Piramal_Pharma #Nitrosamine

#tennessee #pickettcounty #aiimages #iconoplasm #AIArt #AIArtist #AIArtwork #GenArt #DigitalArt #AIArtGallery #AIGeneratedArt #AIArtCommunity #monster #horrorart #digitalart #fantasyai #synthart #lovecraft #nitrosamine #lich #pickett

Official Nitrosamine Lich of Pickett County, Tennessee

Trends and Challenges in Nitrosamine Testing: Part Six – Live Roundtable Kevin Parker, Jessica Hoskins, Alan Thompson, and Yingue Yang discuss trends and challenges in nitrosamine testing during a live webinar – after a quick recap

🧪 What’s next for #nitrosamine testing?

We bring together a panel of experts to tackle one of the most pressing challenges in pharma quality and safety.

🎙️They discuss regulatory expectations, LC-MS strategies, and where the industry is heading next.

▶️ Watch the full roundtable:
ow.ly/JbN150VwkKS

A comprehensive approach for N-nitrosamine determination in pharmaceuticals using a novel HILIC-based solid phase extraction and LC-HRMS N-nitrosamines (NAs) are potentially highly carcinogenic compounds that have recently been detected in traces in various drug products (DPs). Due to t…

#MedSky🧪 #Pharmasky #drugdevelopment #Publichealth @fda.gov CDER experts work with international regulators to develop a methodology, the Carcinogenic Potency Categorization Approach (CPCA), that uses the chemical structure of a #nitrosamine impurity to recommend acceptable intake (AI) limits

Formation of N-Nitrosamine Drug Substance Related Impurities in Medicines: A Regulatory Perspective on Risk Factors and Mitigation Strategies The detection of N-nitrosamine impurities in medicines and the recent emergence of nitrosamine drug substance related impurities (NDSRIs) has posed a great challenge to manufacturers of drug products and regulators alike. NDSRIs are primarily associated with reactions occurring in the drug product which brings particular complexity. This paper will explore the current technical knowledge surrounding the formation of these impurities, including the risk factors, reaction conditions, and potential mitigation strategies. Scientific understanding of these areas is still evolving, and we will highlight both the scientific progress made and discuss the significant gaps in mechanistic knowledge still remaining. These gaps render accurate predictions of NDSRI formation extremely challenging. The pharmaceutical industry should continue to work on potential mitigation strategies and generation of additional scientific data to address the mechanistic gaps. Regulatory guidance and policy will continue to advance and adapt in response to further changes in scientific understanding.

Cioc et al (2023) Formation of N-Nitrosamine Drug Substance Related Impurities in Medicines: A Regulatory Perspective on Risk Factors and Mitigation Strategies. Org Process Res Dev 27:1736–1750 #nitrosamine #OpenAccess #chemsky 🧪
doi.org/10.1021/acs....